Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAGIC: Faricimab for Retinal Non-Perfusion Associated With Non-Proliferative Diabetic Retinopathy
NCT05681884Phase 2Completed
- Sponsor
- Greater Houston Retina Research Center
- Start
- May 2023
- Primary completion
- Feb 2026
- Modality
- Bispecific Antibodies, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of faricimab, sponsored by Greater Houston Retina Research Center. Started May 2023; status: completed.
02
Drugs
faricimab
Beyond the preview
Go deeper on NCT05681884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05681884.